Lonza Group AG (LO3)
XDUS
Closed
Oct 19, 2026
Day's Range
646.8052 wk Range
500.00Overview - LO3 - Lonza Group AG
Key Statistics
Valuation
Enterprise Value
3.82B
P/E (Trailing)
‪-164.83‬
EV / EBITDA
‪1.74‬
Profitability
Profit Margin
‪35.35%‬
Operating Margin
‪19.35%‬
Return on Assets
‪-1.53%‬
Return on Equity
‪-3.45%‬
Ownership
Shares Outstanding
69.84M
Price stats
50-Day Avg
‪602.65‬
200-Day Avg
‪573.52‬
Peers - LO3 - Lonza Group AG
Peer Comparison
Compared with companies in Diagnostics & Research listed on XDUS.
- LO3XDUSLonza Group AG+7.19%52-week change-164.83P/E (Trailing)‪35.35%‬Profit Margin
- NL0XDUSGRAIL, Inc.+53.52%52-week change-10.50P/E (Trailing)‪-236.94%‬Profit Margin
- 0MEXDUSTwist Bioscience Corporation+80.08%52-week change-108.42P/E (Trailing)‪50.72%‬Profit Margin
- 1K9XDUSCareDx, Inc.+77.16%52-week change-137.50P/E (Trailing)‪67.55%‬Profit Margin
- ILUXDUSIllumina, Inc.+65.36%52-week change44.52P/E (Trailing)‪66.08%‬Profit Margin
- 5GHXDUSGuardant Health Inc.+64.22%52-week change-45.10P/E (Trailing)‪64.46%‬Profit Margin
- 1HMXDUSAdaptive Biotechnologies Corporation Common Stock+52.26%52-week change-64.18P/E (Trailing)‪74.23%‬Profit Margin
Profile Summary - LO3 - Lonza Group AG
About
Lonza Group AG is a Swiss-based global leader in contract development and manufacturing organization (CDMO) services for the pharmaceutical, biotech, and nutrition industries. Founded in 1897, it has evolved from electrochemical manufacturing and power generation into the world's largest pure-play CDMO, with over 30…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
